Raymond Huggenberger - Inogen Insider

Inogen Inc -- USA Stock  

USD 121.65  3  2.53%

CEO and Director

Mr. Raymond O. Huggenberger is Independent Director of Inogen, Inc. He has served as a Member of our Board since 2008. Mr. Huggenberger previously served as our Chief Executive Officer from 2008 until March 1, 2017 and as our President from 2008 until January 1, 2016. Prior to joining our company, Mr. Huggenberger held various management positions with Sunrise Medical Inc., a global manufacturer and distributor of durable medical equipment, including Vice President of Marketing for Sunrises German subsidiary from 1994 to 1996, President of Sunrises German division from 1998 until 2000, President of the European Operating Group from 2000 to 2002, President and Chief Operating Officer from 2002 until 2004, and President of European Operations 2006 to 2007. Mr. Huggenberger also held a consultant position with McDermott and Bull Inc., an executive search firm, from 2005 to 2006 and the position of Managing Director in the healthcare division of TA Triumph Adler AG, a document process management firm, from 1996 to 1998. Mr. Huggenberger currently serves on the Board of Directors of Wellfount Corporationrationration, a pharmacy services company, and previously served on the Board of Directors of IYIA Technologies, a healthcare company. Mr. Huggenberger graduated from AKAD University in Rendsburg, Germany in Economics and completed the Advanced Marketing Strategies Program at INSEAD, Fontainebleau, France. The Board believes that he is qualified to serve as a director of Inogen because of his deep understanding of our business, operations and strategy.
Age: 57  CEO Since 2017      
805 562-0500  www.inogen.com

Raymond Huggenberger Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 7.37 % which means that it generated profit of $7.37 on every $100 spent on asset. This is normal as compared to the sector avarege. Similarly, it shows return on stockholders equity (ROE) of 14.24 % meaning that it created $14.24 on every $100 dollars invested by stockholders.

Similar Executives

Found 1 records

CEO Since

Matt MolchanDigirad Corporation
2013

Entity Summary

Inogen, Inc., a medical technology company, primarily develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other clinicians, and thirdparty payors in the United States and internationally. Inogen Inc (INGN) is traded on NASDAQ in USA. It is located in CALIFORNIA, U.S.A and employs 547 people. Inogen is listed under Medical Equipment category by Fama And French industry classification.

Did you try this?

Run Price Transformation Now
   

Price Transformation

Use Price Transformation models to analyze depth of different equity instruments across global markets
Hide  View All  NextLaunch Price Transformation
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Inogen Inc to your portfolio

Top Management

Inogen Inc Leadership Team
Scott Beardsley, Director
Heather Rider, Director, MBA
Loren McFarland, Director, CFA
Scott Greer, Director, MBA
Benjamin AndersonRay, Director, MBA
Scott Wilkinson, COO, MBA
Brenton Taylor, Founder
R Greer, Director, MBA
Byron Myers, Founder, MBA
Raymond Huggenberger, CEO
Heath Lukatch, Chairman, Ph.D
Matthew Scribner, President, MBA
Alison Bauerlein, Founder

Stock Performance

Inogen Performance Indicators